> Moderna's goal with this trial was to show their tailored vaccine outperformed a COVID vaccine (for example), and my assumption from the stock dip is that smarter people than I were not convinced.

The trial result is excellent - anyone ‘not convinced’ was not living in the realm of typical results.

Please note this has about nothing whatsoever to do with COVID. It’s probably best not to comment on technical topics if you have no relevant experience.

This has everything to do with mRNA vaccines effects on cancer reoccurrence. The COVID vaccine just happens to be the most common and therefore most studied.